FLAREX

This brand name is authorized in United States. It is also authorized in Australia, Canada, Hong Kong SAR China, Lithuania, Malta, Poland, Turkey.

Active ingredients

The drug FLAREX contains one active pharmaceutical ingredient (API):

1	Fluorometholone UNII 9I50C3I3OK - FLUOROMETHOLONE ACETATE
	Fluorometholone is a synthetic corticosteroid (glucocorticoid), a derivative of desoxyprednisolone. It is a member of the group of universally known steroids used for the treatment of eye inflammation. Glucocorticosteroids bind to cytoplasmic receptors and control the synthesis of infection mediators thus damping inflammatory reactions (swelling, fibrin deposition, capillary dilatation, phagocyte migration) and also capillary proliferation, collagen deposition and scarring.
	Read more about Fluorometholone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLAREX Eye drops, suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BA07	Fluorometholone	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1438Q, 5533F
CA	Health Products and Food Branch	00756784
HK	Department of Health Drug Office	45275
LT	Valstybinė vaistų kontrolės tarnyba	1012590
MT	Medicines Authority	MA1249/01701
PL	Rejestru Produktów Leczniczych	100092631
TR	İlaç ve Tıbbi Cihaz Kurumu	8699839611468
US	FDA, National Drug Code	0065-0096, 71776-100